Comparing ESPB and SPSIPB nerve blocks for pain after VATS
Comparison of the Effects of Ultrasound-Guided Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block on Postoperative Analgesia Management in Patients Undergoing Video-Assisted Thoracoscopic Surgery
This trial will test whether the serratus posterior superior intercostal plane block (SPSIPB) or the erector spinae plane block (ESPB) gives better pain relief and satisfaction for adults having VATS.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Bursa City Hospital Government |
| Locations | 1 site (Bursa, Nilüfer) |
| Trial ID | NCT07232940 on ClinicalTrials.gov |
What this trial studies
Video-assisted thoracoscopic surgery (VATS) causes significant postoperative pain despite small incisions, and effective regional analgesia is important to reduce acute and chronic pain. Current PROSPECT guidance supports ESPB or paravertebral block for VATS, while the serratus posterior superior intercostal plane block (SPSIPB) is a recently described technique that may cover C3–T10 dermatomes. This study will compare postoperative analgesic efficacy and patient satisfaction between ESPB and SPSIPB in adult elective VATS patients treated at Bursa City Hospital. Typical inclusion criteria are adults 18–65 years with ASA I–III, with exclusions for coagulopathy, local anesthetic allergy, chronic opioid use, uncontrolled major comorbidities, infection at the injection site, and pregnancy or breastfeeding.
Who should consider this trial
Good fit: Adults aged 18–65 with ASA physical status I–III scheduled for elective VATS who do not have contraindications to regional nerve blocks are ideal candidates.
Not a fit: Patients with coagulopathy, local infection at the injection site, known local anesthetic allergy, current chronic opioid therapy, uncontrolled systemic disease, or pregnancy are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If one block provides better and longer pain relief with fewer opioid needs, patients could experience less acute pain, lower opioid use, and potentially lower risk of chronic postoperative pain after VATS.
How similar studies have performed: ESPB and paravertebral blocks have prior supportive data for VATS analgesia, whereas SPSIPB is a newly described technique with limited comparative evidence to date.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18-65 years with ASA physical status I-III who will undergo elective video-assisted thoracoscopic surgery (VATS) will be included. Exclusion Criteria: * Patients who do not consent to participate in the study Patients with coagulopathy Patients with a history of local anesthetic allergy or toxicity Patients with hepatic or renal failure Patients with uncontrolled diabetes Patients with uncontrolled hypertension Mentally disabled patients Patients receiving chronic pain treatment (opioid users) Patients using antidepressant medication Patients with neuropathic pain Mentally disabled patients Presence of infection at the injection site Pregnant or breastfeeding women, or those with suspected pregnancy
Where this trial is running
Bursa, Nilüfer
- Bursa City Hospital — Bursa, Nilüfer, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Eralp Çevikkalp
- Email: eralpcevikkalp@hotmail.com
- Phone: +905054554875
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.